mdi-book-open-variant Impressum mdi-help Hilfe / Anleitung mdi-printer Webseite ausdrucken mdi-bookmark Bookmark der Webseite speichern mdi-magnify Suche & Index Wirkstoffe mdi-sitemap Sitemap CliniPharm/CliniTox-Webserver mdi-home Startseite CliniPharm/CliniTox-Webserver mdi-email Beratungsdienst: Email / Post / Fax / Telefon

Marks CA
Hypertrophic cardiomyopathy in a dog.

J Am Vet Med Assoc, 203(7): 1020-1022, 1993
ISSN: 0003-1488 Journal of the American Veterinary Medical Association (PubMed)

Abstract
A 12-year-old spayed Corgi with heart failure did not respond to conventional medical therapy for congestive cardiomyopathy (furosemide, 2.5 mg/kg of body weight, IV, q 8 h; captopril 1 mg/kg, PO, q 8 h). Cardiac ultrasonography subsequently revealed a hypertrophic left ventricle and interventricular septum. Because a causative agent could not be identified, a diagnosis of primary hypertrophic cardiomyopathy was made. Administration of diltiazem (1.25 mg/kg, PO, q 12 h) resulted in sustained clinical improvement for several weeks. Complete cardiac evaluation, including echocardiography, was essential in determining the correct treatment for this dog.

© 2021 - Institut für Veterinärpharmakologie und ‑toxikologie

Es kann keinerlei Haftung für Ansprüche übernommen werden, die aus dieser Webseite erwachsen könnten.